PH20568A - Dietary and pharmaceutical uses of methyl sulfonylmethane and compositions comprising it - Google Patents

Dietary and pharmaceutical uses of methyl sulfonylmethane and compositions comprising it

Info

Publication number
PH20568A
PH20568A PH29542A PH29542A PH20568A PH 20568 A PH20568 A PH 20568A PH 29542 A PH29542 A PH 29542A PH 29542 A PH29542 A PH 29542A PH 20568 A PH20568 A PH 20568A
Authority
PH
Philippines
Prior art keywords
dietary
compositions
pharmaceutical uses
methyl sulfonylmethane
methylsulfonylmethane
Prior art date
Application number
PH29542A
Other languages
English (en)
Inventor
Robert J Herschler
Original Assignee
Herschler R J
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Herschler R J filed Critical Herschler R J
Publication of PH20568A publication Critical patent/PH20568A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A61K31/10—Sulfides; Sulfoxides; Sulfones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
PH29542A 1982-09-14 1983-09-14 Dietary and pharmaceutical uses of methyl sulfonylmethane and compositions comprising it PH20568A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/418,110 US4514421A (en) 1979-08-30 1982-09-14 Dietary and pharmaceutical uses of methylsulfonylmethane and compositions comprising it

Publications (1)

Publication Number Publication Date
PH20568A true PH20568A (en) 1987-02-18

Family

ID=23656756

Family Applications (1)

Application Number Title Priority Date Filing Date
PH29542A PH20568A (en) 1982-09-14 1983-09-14 Dietary and pharmaceutical uses of methyl sulfonylmethane and compositions comprising it

Country Status (13)

Country Link
US (1) US4514421A (ru)
EP (1) EP0103836B1 (ru)
JP (1) JPS59501748A (ru)
AT (1) ATE60234T1 (ru)
AU (2) AU564536B2 (ru)
CA (1) CA1219218A (ru)
DE (1) DE3382136D1 (ru)
DK (1) DK238384D0 (ru)
NO (1) NO841909L (ru)
NZ (1) NZ205571A (ru)
PH (1) PH20568A (ru)
SU (1) SU1443788A3 (ru)
WO (1) WO1984001105A1 (ru)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4914135A (en) * 1979-08-30 1990-04-03 Herschler R J Use of Methylsulfonylmethane to treat parasitic infections
US4514421A (en) * 1979-08-30 1985-04-30 Herschler R J Dietary and pharmaceutical uses of methylsulfonylmethane and compositions comprising it
US4863748A (en) * 1979-08-30 1989-09-05 Herschler R J Dietary products and uses comprising methylsulfonylmethane
US4616039A (en) 1979-08-30 1986-10-07 Herschler R J Methylsulfonylmethane in dietary products
WO1994005293A1 (en) * 1992-09-04 1994-03-17 Aws Shakir Mustafa Salim Skin treatment compositions containing dimethylsulphone and allopurinol or oxypurinol
GB9218711D0 (en) * 1992-09-04 1992-10-21 Salim Aws S M Skin cancer treatment
US6426085B1 (en) 1994-05-02 2002-07-30 Josman Laboratories Inc. Use of bismuth-containing compounds in topical oral dosage forms for the treatment of halitosis
US6902738B2 (en) * 1994-05-02 2005-06-07 Josman Laboratories, Inc. Topical oral dosage forms containing bismuth compounds
US5834002A (en) 1994-05-02 1998-11-10 Josman Laboratories, Inc. Chewing gum containing colloidal bismuth subcitrate
US5569679A (en) * 1994-12-30 1996-10-29 Russell A. Krueger Pharmaceuticals, Inc. Pharmacologic management of snoring
US6379651B1 (en) 1995-02-07 2002-04-30 Josman Laboratories Oral-topical dosage forms for delivering antibacterials/antibiotics to oral cavity to eradicate H. pylori as a concomitant treatment for peptic ulcers and other gastro-intestinal diseases
US6372784B1 (en) 1995-02-07 2002-04-16 Josman Laboratories, Inc. Bismuth-containing compounds in topical dosage forms for treatment of corneal and dermal wounds
JPH11504939A (ja) * 1995-05-09 1999-05-11 ザ、プロクター、エンド、ギャンブル、カンパニー 胃腸障害の治療及び予防用のビスマス含有組成物
DE69636254T2 (de) * 1995-08-24 2006-12-14 Josman Laboratories, Inc., Orange Bismut enthaltende arzneimittel in topischen darreichungsformen
US5827543A (en) * 1995-12-07 1998-10-27 The Procter & Gamble Company Methods and compositions for the prevention and treatment of urogenital disorders
EP0776665B1 (en) * 1995-12-07 2003-02-19 The Procter & Gamble Company Compositons for the prevention and treatment of urogenital disorders, containing bismuth
US5744168A (en) * 1995-12-07 1998-04-28 The Procter & Gamble Company Methods and compositions for the prevention and treatment of gastrointestinal disorders
US5702729A (en) * 1995-12-07 1997-12-30 The Procter & Gamble Company Methods for the prevention and treatment of gastrointestinal disorders caused or mediated by algae or cyanobacteria
US6051604A (en) * 1995-12-07 2000-04-18 The Proctor & Gamble Company Methods and compositions for the prevention and treatment of gastrointestinal disorders
CA2239422C (en) * 1995-12-07 2003-03-11 The Procter & Gamble Company Compositions, containing bismuth, for the prevention and treatment of gastrointestinal disorders
US7718694B2 (en) * 1997-10-16 2010-05-18 Children's Hospital & Research Center At Oakland Compositions and methods for therapy for diseases characterized by defective chloride transport
US6203820B1 (en) 1998-05-28 2001-03-20 Brice E. Vickery Compositions and methods for enhancing protein anabolism and detoxification
EP1220678B1 (en) * 1999-10-04 2007-03-07 John Carter Pharmaceutical compositions containing copper, salicylic acid and vitamin c
US6787164B2 (en) 2000-02-23 2004-09-07 Bioselect Innovations, Inc. Composition and method for treating the effects of diseases and maladies
US6841544B2 (en) * 2000-02-23 2005-01-11 Bioselect Innovations, Inc. Composition and method for treating the effects of diseases and maladies
US6793942B2 (en) 2000-02-23 2004-09-21 Bioselect Innovations, Inc. Composition and method for treating the effects of diseases and maladies
US6759062B2 (en) 2000-02-23 2004-07-06 Bioselect Innovations, Inc. Composition and method for treating the effects of diseases and maladies
US6403116B1 (en) 2000-11-03 2002-06-11 Triarco Inductries, Inc. Coenzyme Q10 formulation
US20040038864A1 (en) * 2002-06-27 2004-02-26 Per Balschmidt Use of dimethyl sulfone as isotonicity agent
US20040029774A1 (en) * 2002-08-06 2004-02-12 Aly Gamay Composition and methods for the treatment of musculoskeletal disorders and collagen and elastin deficiencies
US20040082667A1 (en) * 2002-10-16 2004-04-29 Mccadden Kenneth Hangover treatment
JP2005298412A (ja) * 2004-04-13 2005-10-27 Minato Pharmaceutical Co Ltd 被覆粒子
JPWO2005112667A1 (ja) * 2004-05-20 2008-03-27 隆史 大森 健康食品
ITBS20040068A1 (it) * 2004-05-24 2004-08-24 Gen Topics Srl Composizione cosmetica e/o farmaceutica per il trattamento della rosacea
US20060147423A1 (en) * 2004-12-07 2006-07-06 Jean-Yves Legendre Transungual device
US8435224B2 (en) 2005-09-12 2013-05-07 Abela Pharmaceuticals, Inc. Materials for facilitating administration of dimethyl sulfoxide (DMSO) and related compounds
JP5399072B2 (ja) 2005-09-12 2014-01-29 アベラ ファーマスーティカルズ インコーポレイテッド ジメチルスルホキシド（ｄｍｓｏ）若しくは関連化合物、又はそれに関連する臭気を除去するシステム
US8480797B2 (en) 2005-09-12 2013-07-09 Abela Pharmaceuticals, Inc. Activated carbon systems for facilitating use of dimethyl sulfoxide (DMSO) by removal of same, related compounds, or associated odors
EP1937286B1 (en) 2005-09-12 2016-03-09 Abela Pharmaceuticals, Inc. Compositions comprising dimethyl sulfoxide (dmso)
US7754256B2 (en) * 2007-03-07 2010-07-13 Stan Dennison Nutritional composition
BRPI0921494A2 (pt) * 2008-11-03 2018-10-30 Prad Reasearch And Development Ltd método de planejamento de uma operação de amostragem para uma formação subterrãnea, método de contolar uma operação de amostragem de formação subterrânea, método de controlar uma operação de perfuração para uma formação subterrãnea, e método de realizar uma amostragem durante a operação de perfuração.
EA019538B1 (ru) * 2009-04-30 2014-04-30 Бактериефритт Ас Композиция для стерилизации поверхностей
KR20120093993A (ko) 2009-10-30 2012-08-23 아벨라 파마슈티칼스, 인코포레이티드 퇴행성 관절염 치료를 위한 디메틸설폭사이드 및 메틸설포닐메탄 제제
CA2778142C (en) * 2009-10-30 2018-04-24 Biogenic Innovations, Llc Methylsulfonylmethane (msm) for treatment of drug resistant microorganisms
EP2552200B1 (en) * 2010-03-31 2015-10-14 Abela Pharmaceuticals, Inc. Dimethyl sulfoxide (dmso) formulations for treating autism
WO2013150292A1 (en) * 2012-04-02 2013-10-10 Eaglepharma Pty Ltd Composition for the treatment of inflammatory and immune disorders
WO2016010284A1 (ko) * 2014-07-16 2016-01-21 유한회사 비엔트리니티 울금을 함유한 치약 조성물 및 그 제조 방법

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL26209A (en) * 1965-08-02 1970-10-30 Merck & Co Inc Pharmaceutical compositions containing substituted sulphones
US4333922A (en) * 1974-09-12 1982-06-08 Herschler R J Method for the treatment of water-living animals with health modifying agents
US4514421A (en) * 1979-08-30 1985-04-30 Herschler R J Dietary and pharmaceutical uses of methylsulfonylmethane and compositions comprising it
US4296130A (en) * 1979-08-30 1981-10-20 Herschler R J Methylsulfonylmethane and methods of use

Also Published As

Publication number Publication date
NO841909L (no) 1984-05-11
AU7473287A (en) 1987-10-08
EP0103836B1 (en) 1991-01-23
US4514421A (en) 1985-04-30
CA1219218A (en) 1987-03-17
EP0103836A2 (en) 1984-03-28
ATE60234T1 (de) 1991-02-15
NZ205571A (en) 1986-09-10
JPS59501748A (ja) 1984-10-18
AU2039683A (en) 1984-04-04
DK238384A (da) 1984-05-14
AU599670B2 (en) 1990-07-26
DK238384D0 (da) 1984-05-14
EP0103836A3 (en) 1986-07-30
SU1443788A3 (ru) 1988-12-07
WO1984001105A1 (en) 1984-03-29
DE3382136D1 (de) 1991-02-28
AU564536B2 (en) 1987-08-13

Similar Documents

Publication Publication Date Title
PH20568A (en) Dietary and pharmaceutical uses of methyl sulfonylmethane and compositions comprising it
DE3680930D1 (de) Sich schnell verfluessigende kautablette.
AU584685B2 (en) Pharmaceutical and dietary compositions
ES2152966T3 (es) Formas de dosificado farmaceuticas de desleido rapido y procedimiento para su preparacion.
ATE58471T1 (de) Ibuprofen und aluminiumhydroxid enthaltendes arzneimittel.
CA2303537A1 (en) Solid oral dosage form comprising a combination of metformin and glibenclamide
MY103525A (en) Pharmaceutical composition comprising cefuroxime axetil
OA09023A (fr) Composition pharmaceutique, administrable par voie orale, destinée à réduire les effets des b-lactamines.
KR840005662A (ko) 진통캡슐제의 제조방법
JPS6466159A (en) Vanadyl organic-inorganic compound and manufacture of drug composition containing same
US4743596A (en) Anti-arthritic preparation
KR960000217A (ko) L- 카르니틴염과 이를 함유한 조성물
BE901073A (fr) Composition antidiuretique a usage oral.
CA2038744A1 (en) Pharmaceutical composition containing slightly water-soluble drug
KR870002845A (ko) 식욕조절 및 위암억제용 조성물
US4446132A (en) Nontoxic aspirin composition
ATE15331T1 (de) Verfahren fuer die orale verabreichung von substanzen in der form von liposomen, und ihre pharmazeutischen zusammensetzungen.
JPS55122715A (en) Antidiabetic agent
EP0228239A3 (en) Preparation of a medicament for arthritis and rheumatism
PT84580A (en) Process for the preparation of pharmaceutical compositions containing indomethacin
JPS5498791A (en) Anti-asthmatic drug
JPS59139322A (ja) 下痢治療剤
DE3171821D1 (en) Pharmaceutical compositions
JPS57167912A (en) Antitumor agent
EP0009046A1 (en) Composition containing salicylsalicyclic acid and acetaminophen